118754-54-4 Usage
Uses
Used in Chemical Synthesis:
2,6-Dichloro-4-(trifluoromethoxy)benzaldehyde is used as a reagent in chemical synthesis for its strong electrophilic properties. Its unique combination of functional groups allows for versatile applications in the creation of new compounds and materials.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2,6-dichloro-4-(trifluoromethoxy)benzaldehyde is used as an intermediate in the synthesis of various drug molecules. Its electrophilic nature and functional groups enable the development of new therapeutic agents with potential medicinal properties.
Used in Material Science:
2,6-Dichloro-4-(trifluoromethoxy)benzaldehyde is employed as a building block in the development of novel materials with specific properties. Its chemical structure contributes to the creation of advanced materials for applications in various fields, such as electronics, coatings, and adhesives.
Used in Research and Development:
In research and development settings, 2,6-dichloro-4-(trifluoromethoxy)benzaldehyde serves as a key compound for exploring new chemical reactions and mechanisms. Its unique properties make it an important tool for advancing scientific understanding and discovering new applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 118754-54-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,8,7,5 and 4 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 118754-54:
(8*1)+(7*1)+(6*8)+(5*7)+(4*5)+(3*4)+(2*5)+(1*4)=144
144 % 10 = 4
So 118754-54-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H3Cl2F3O2/c9-6-1-4(15-8(11,12)13)2-7(10)5(6)3-14/h1-3H
118754-54-4Relevant academic research and scientific papers
TETRACYCLIC INHIBITORS OF JANUS KINASES
-
Page/Page column 108, (2008/06/13)
The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
